Related Experiment Video

Updated: Jun 15, 2026

Generation of Human Chimeric Antigen Receptor Regulatory T Cells
10:29

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

CARMA1 regulation of regulatory T cell development involves modulation of interleukin-2 receptor signaling

Andrew Joon Lee1, Xuefeng Wu, Hanyin Cheng

  • 1Department of Immunology, The University of Texas MD Anderson Cancer Center, University of Texas, Houston, Texas 77030, USA.

The Journal of Biological Chemistry
|March 18, 2010
PubMed

Insights

CYLD deficiency constitutively activates NF-kappaB in thymocytes, enhancing regulatory T cell (Treg) frequency. CARMA1 regulates Treg development via IL-2 signaling, independent of this NF-kappaB activation.

Area of Science:

  • Immunology
  • Cellular signaling

Background:

  • NF-kappaB activation is crucial for T cell receptor signaling and is regulated by CARMA1 and CYLD.
  • Regulatory T cells (Tregs) are vital for immune homeostasis, and their development is linked to CARMA1 signaling, but the precise role of NF-kappaB remains unclear.

Purpose of the Study:

  • To investigate the role of CYLD in NF-kappaB activation and its impact on regulatory T cell (Treg) development.
  • To elucidate the mechanisms by which CARMA1 influences Treg development, particularly concerning NF-kappaB and IL-2 signaling.

Main Methods:

  • Analysis of NF-kappaB activation in thymocytes from wild-type, CYLD-deficient, CARMA1-deficient, and double-knockout mice.
  • Assessment of Treg cell frequency in these mouse models.
  • Investigation of the effects of inhibiting canonical NF-kappaB signaling on Treg development.
  • Examination of CARMA1's role in IL-2 receptor signaling and Treg precursor maturation.

Main Results:

  • CYLD deficiency led to constitutive NF-kappaB activation in thymocytes, independent of CARMA1, and increased Treg cell frequency.
  • Loss of CYLD did not rescue the impaired Treg development observed in CARMA1-knockout mice.
  • Inhibition of canonical NF-kappaB partially affected Treg development.
  • CARMA1 was found to regulate IL-2 receptor signaling, controlling the maturation of Treg precursors.

Conclusions:

  • CYLD-mediated regulation of NF-kappaB is not the primary driver of CARMA1-dependent Treg development.
  • CARMA1 plays a critical role in Treg development through both NF-kappaB activation and modulation of IL-2 receptor signaling pathways.

More Related Videos

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice07:17

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice

Published on: June 22, 2016

Retroviral Transduction of Helper T Cells as a Genetic Approach to Study Mechanisms Controlling their Differentiation and Function11:50

Retroviral Transduction of Helper T Cells as a Genetic Approach to Study Mechanisms Controlling their Differentiation and Function

Published on: November 4, 2016

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...